5 completed. 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 5 |
Follow caspofungin acetate: new trials by email Literature Review of caspofungin acetate trials Research Report on caspofungin acetate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Open, Pharmacokinetic Study of Caspofungin in Neonates and Infants (0991-058) caspofungin acetate - Candidiasis | Phase 2 | Completed | Merck Sharp & Dohme LLC | 16 | 2006-05-01 | 2017-02-23 |
| Caspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell Transplant caspofungin acetate - Cancer | Phase 2 | Completed | European Organisation for Research and Treatment of Cancer - EORTC | 171 | 2005-02-01 | 2012-09-24 |
| Open, Pharmacokinetic Study of Caspofungin Acetate in Immunocompromised Young Children With Febrile Neutropenia (0991-042) caspofungin acetate - Fungal Infection | Phase 2 | Completed | Merck Sharp & Dohme LLC | 16 | 2004-05-01 | 2017-02-23 |
| Documented Candida or Aspergillus Infections in Pediatric Patients (0991-043) caspofungin acetate - Aspergillosis, Candidiasis | Phase 2 | Completed | Merck Sharp & Dohme LLC | 50 | 2004-04-01 | 2017-02-23 |
| MK0991 Versus Amphotericin B for Empirical Therapy in Febrile, Neutropenic Pediatric Patients (0991-044) caspofungin acetate, Comparator: AmBisome - Neutropenia, Fever | Phase 2 | Completed | Merck Sharp & Dohme LLC | 100 | 2004-04-01 | 2017-02-23 |
Candidiasis (2) · Aspergillosis (1) · Ataxia Telangiectasia (1) · Blast Crisis (1) · Breast Neoplasms (1) · Burkitt Lymphoma (1) · Carcinoma, Ovarian Epithelial (1) · Congenital Abnormalities (1) · Fever (1) · Hodgkin Disease (1) · Immunoblastic Lymphadenopathy (1) · Immunoglobulin Light-chain Amyloidosis (1) · Infections (1) · Intraocular Lymphoma (1) · Leukemia, Biphenotypic, Acute (1)
Merck Sharp & Dohme LLC (4) · European Organisation for Research and Treatment of Cancer - EORTC (1)
Belgium (1) · France (1) · Germany (1) · Italy (1) · Slovakia (1) · Switzerland (1) · Turkey (Türkiye) (1)